Tumor budding - A promising prognostic histopathological parameter in oral squamous cell carcinoma - A comparative immunohistochemical study
- PMID: 33967517
- PMCID: PMC8083399
- DOI: 10.4103/jomfp.JOMFP_74_20
Tumor budding - A promising prognostic histopathological parameter in oral squamous cell carcinoma - A comparative immunohistochemical study
Abstract
Introduction: The majority of the head and neck squamous cell carcinomas (HNSCC) occur in the oral cavity. Even with advances in cancer therapy only minor improvements in the survival of HNSCC patients have taken place and approximately 350,000 patients die annually of HNSCC worldwide. Tumor budding (TB) is a novel and promising histo-morphological parameter that has been studied in many cancers. The presence of TB is associated with lymph node and distant metastasis as well as poor survival, independently of the applied scoring system. The depth of tumor invasion (D) measured from the surface of the tumor to the deepest point of invasion is also an important prognostic parameter for oral squamous cell carcinoma (OSCC) with a cutoff point of 4 mm. Both taken together constitute BD model and it has also been found to be an independent prognostic factor for patients with OSCC. Therefore, it would be highly beneficial to evaluate TB and BD model in routine histopathological reporting.
Aims and objectives: This study aims to compare the detection of TB in hematoxylin-eosin and pan-cytokeratin stained immune-histochemical sections of OSCC and also to evaluate whether BD score can serve as a reliable prognostic indicator for OSCC.
Methodology: A total of 30 formalin-fixed, paraffin-embedded tissue blocks of clinically and histopathologically diagnosed cases of OSCC were retrieved. One section was stained with hematoxylin and eosin and the other was processed for pancytokeratin immunohistochemistry to evaluate tumor buds. Depth of invasion (D) was also evaluated to achieve the BD score.
Results: Statistical significance (P < 0.001) was noted between TB score evaluated in hematoxylin and eosin (H&E) and pancytokeratin stained sections. There was no statistical significance between age, gender, site of lesion, clinical staging, survival and BD score.
Conclusion: Immunohistochemical analysis of TB is superior to H&E staining in detection of tumor buds at the tumor invasive front.
Keywords: BD score; depth of invasion; oral squamous cell carcinoma; tumor budding.
Copyright: © 2021 Journal of Oral and Maxillofacial Pathology.
Conflict of interest statement
There are no conflicts of interest.
Figures





Similar articles
-
The Emerging Impact of Tumor Budding in Oral Squamous Cell Carcinoma: Main Issues and Clinical Relevance of a New Prognostic Marker.Cancers (Basel). 2022 Jul 22;14(15):3571. doi: 10.3390/cancers14153571. Cancers (Basel). 2022. PMID: 35892830 Free PMC article. Review.
-
Prognostic evaluation of tumour budding in oral squamous cell carcinoma: Evidenced by CD44 expression as a cancer stem cell marker.Pathol Res Pract. 2023 Nov;251:154883. doi: 10.1016/j.prp.2023.154883. Epub 2023 Oct 17. Pathol Res Pract. 2023. PMID: 37898041
-
Pancytokeratin immunostained tumor buds and cytoplasmic pseudofragments are reliable early predictive variables for regional lymph node metastatic risk assessment of oral squamous cell carcinoma.Indian J Dent Res. 2020 Nov-Dec;31(6):904-910. doi: 10.4103/ijdr.IJDR_101_19. Indian J Dent Res. 2020. PMID: 33753662
-
The budding and depth of invasion model in oral cancer: A systematic review and meta-analysis.Oral Dis. 2022 Mar;28(2):275-283. doi: 10.1111/odi.13671. Epub 2020 Oct 25. Oral Dis. 2022. PMID: 33031610
-
The Evaluation of Tumor Budding in Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis.Cureus. 2024 Sep 21;16(9):e69830. doi: 10.7759/cureus.69830. eCollection 2024 Sep. Cureus. 2024. PMID: 39435243 Free PMC article.
Cited by
-
Impact of Tumor Budding in Head and Neck Cancers on Neck Lymph Node Metastasis and Prognosis.J Clin Med. 2025 Jul 23;14(15):5224. doi: 10.3390/jcm14155224. J Clin Med. 2025. PMID: 40806845 Free PMC article.
-
Tumour Budding in Oral Squamous Cell Carcinoma: A Narrative Review.Cureus. 2024 Sep 17;16(9):e69624. doi: 10.7759/cureus.69624. eCollection 2024 Sep. Cureus. 2024. PMID: 39429322 Free PMC article. Review.
-
The Emerging Impact of Tumor Budding in Oral Squamous Cell Carcinoma: Main Issues and Clinical Relevance of a New Prognostic Marker.Cancers (Basel). 2022 Jul 22;14(15):3571. doi: 10.3390/cancers14153571. Cancers (Basel). 2022. PMID: 35892830 Free PMC article. Review.
-
Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer.Br J Cancer. 2023 Jun;128(12):2295-2306. doi: 10.1038/s41416-023-02240-y. Epub 2023 Apr 12. Br J Cancer. 2023. PMID: 37045906 Free PMC article.
References
-
- Almangush A, Salo T, Hagström J, Leivo I. Tumour budding in head and neck squamous cell carcinoma-a systematic review. Histopathology. 2014;65:587–94. - PubMed
-
- Sawazaki-Calone I, Rangel A, Bueno AG, Morais CF, Nagai HM, Kunz RP, et al. The prognostic value of histopathological grading systems in oral squamous cell carcinomas. Oral Dis. 2015;21:755–61. - PubMed
-
- Almangush A, Coletta RD, Bello IO, Bitu C, Keski-Säntti H, Mäkinen LK, et al. A simple novel prognostic model for early stage oral tongue cancer. Int J Oral Maxillofac Surg. 2015;44:143–50. - PubMed
-
- Attramadal CG, Kumar S, Boysen ME, Dhakal HP, Nesland JM, Bryne M. Tumor budding, EMT and cancer stem cells in T1-2/N0 oral squamous cell carcinomas. Anticancer Res. 2015;35:6111–20. - PubMed
LinkOut - more resources
Full Text Sources